RÉSUMÉ
Colorectal cancer, developing from malignant transformation of the distal gut epithelium, is the second leading cause of cancer death in the United States. We present a gentleman in his 60s who was diagnosed with colorectal cancer during a routine screening colonoscopy with no evidence of distant metastasis on subsequent staging with positron emission tomography and computed tomography (PET-CT). The outside rectal MR (magnetic resonance) imaging report localized a mass to the upper rectum. Review of the MRI at an institutional, Multidisciplinary Tumor Board designated the tumor as "rectosigmoid," straddling the rectosigmoid junction at the level of the "sigmoid take-off" (STO) or alternatively at the level of the last sigmoid artery take-off (SAT) at the origin of the superior rectal artery. The anatomic differentiation between upper rectal and lower sigmoid colon cancers carries clinical importance which is highlighted in this case report and brief literature review. Optimal anatomic localization of colorectal cancers helps direct the clinical team to tailor an individualized patient care plan.
RÉSUMÉ
Colorectal carcinoma with noncohesive tumor cells has been described in tumors with signet ring cells (mucinous adenocarcinoma and signet ring cell adenocarcinoma) and rhabdoid feature (carcinoma with sarcomatoid component). Cases of carcinoma with plasmacytoid morphology are rare in the gastrointestinal tract, and a single case of plasmacytoid colorectal carcinoma has been reported. We report the case of a 37-year-old woman who presented with urinary symptoms, hematuria, and abdominal pain. Imaging studies showed segmental sigmoid wall thickening with pericolic infiltration and focal bladder wall thickening. The cystoscopy with transurethral resection of bladder tumor revealed muscle invasion, dis-cohesive carcinoma with plasmacytoid morphology, which was initially misdiagnosed as the plasmacytoid urothelial carcinoma. Immunohistochemical stains showed the tumor cells to be positive for CDX2, CK20, and SATB2 and negative for p63, GATA3, CK7, and Uroplakin II, indicating the colorectal origin of the tumor. The subsequent colonic wall biopsy showed the same tumor. Molecular studies identified BRAF V600E, SMAD4, and p53 mutations associated with aggressive colorectal adenocarcinoma with mucinous/signet ring cell features. Further whole-exome sequencing and whole transcriptome analysis confirmed the colorectal origin of the tumor. This rare colorectal adenocarcinoma with the plasmacytoid feature may represent the signet ring cell adenocarcinoma lacking extracellular mucin or intracellular vacuole. Diagnosis of this rare histological subtype of colorectal carcinoma is important, particularly in the unusual presentation of this aggressive tumor.
RÉSUMÉ
PURPOSE: To assess the effectiveness and safety of prostatic artery embolization (PAE) on lower urinary tract symptoms (LUTS) in the setting of localized prostate cancer (PCa). MATERIALS AND METHODS: This was a retrospective, single-center, institutional review board-approved study from December 2016 to June 2020 of 21 patients (median age, 72; range, 63-83 years) with moderate LUTS and localized PCa. Clinical effectiveness was evaluated at 6 and 12 weeks using International Prostate Symptom Score (IPSS) and quality of life (QoL) improvement. Seventeen patients were scheduled to receive definitive radiotherapy (RT) after PAE; 13 patients completed RT. Short-term imaging signs of oncologic progression were evaluated at 6 and 12 weeks defined by at least one of the following on magnetic resonance imaging: increased Prostate Imaging-Reporting and Data System score of index lesion(s) to at least 4, new extracapsular extension, seminal vesicle involvement, or pelvic lymphadenopathy. Nonparametric Wilcoxon signed-rank test was used for analysis. RESULTS: IPSS improved by a median of 12 (n = 19, P < .0001) and 14 (n = 14, P < .0001) at 6 and 12 weeks, respectively. QoL improved by a median of 2 (n = 19, P < .0001) and 3 (n = 3, P < .0001) at 6 and 12 weeks. Prostate volume decreased by a median of 24% (n = 19, P < .0001) and 36% (n = 12, P = .015) at 6 and 12 weeks. No patients demonstrated disease progression at 6 (n = 16) or 12 (n = 8) weeks by imaging. No patients experienced increased prostate-specific antigen after RT, grade ≥3 adverse events, or greater genitourinary toxicity. CONCLUSIONS: PAE is effective and safe for the treatment of men with LUTS from benign prostatic hyperplasia in the setting of concomitant, localized, non-obstructive PCa.
Sujet(s)
Embolisation thérapeutique , Symptômes de l'appareil urinaire inférieur , Hyperplasie de la prostate , Tumeurs de la prostate , Sujet âgé , Artères/imagerie diagnostique , Embolisation thérapeutique/effets indésirables , Humains , Symptômes de l'appareil urinaire inférieur/étiologie , Symptômes de l'appareil urinaire inférieur/thérapie , Mâle , Hyperplasie de la prostate/complications , Hyperplasie de la prostate/imagerie diagnostique , Hyperplasie de la prostate/thérapie , Tumeurs de la prostate/imagerie diagnostique , Tumeurs de la prostate/thérapie , Qualité de vie , Études rétrospectives , Résultat thérapeutiqueRÉSUMÉ
A nonoperative management strategy, or Watch-and-Wait, following neoadjuvant therapies of locally advanced rectal adenocarcinoma is increasingly considered for select patients. Yet, standardized tumor response assessment to best select and surveil suitable patients remains an unmet clinical challenge. Endoscopic and MRI currently provide the most reliable tumor response estimations. However, resources illustrating variable tumor responses to neoadjuvant therapies remain limited. This pictorial review aims to provide detailed and annotated examples of common endoscopic and MRI findings of rectal cancer treatment response, while also emphasizing their respective diagnostic shortcomings and consequently, the necessity for a multidisciplinary approach to optimally manage these patients.
Sujet(s)
Traitement néoadjuvant , Tumeurs du rectum , Humains , Imagerie par résonance magnétique , Récidive tumorale locale , Tumeurs du rectum/imagerie diagnostique , Tumeurs du rectum/thérapie , Rectum , Résultat thérapeutique , Observation (surveillance clinique)RÉSUMÉ
Colorectal cancer is the third most common cancer in men and the second most common in women worldwide, and the incidence is increasing among younger patients. 30% of these malignancies arise in the rectum. Patients with rectal cancer have historically been managed with preoperative radiation, followed by radical surgery, and adjuvant chemotherapy, with permanent colostomies in up to 20% of patients. Beginning in the early 2000s, non-operative management (NOM) of rectal cancer emerged as a viable alternative to radical surgery in select patients. Efforts have been ongoing to optimize neoadjuvant therapy for rectal cancer, thereby increasing the number of patients potentially eligible to forgo radical surgery. Magnetic resonance guided radiotherapy (MRgRT) has recently emerged as a treatment modality capable of intensifying preoperative radiation therapy for rectal cancer patients. This technology may also predict which patients will achieve a complete response to preoperative therapy, thereby allowing for more appropriate selection of patients for NOM. The present work seeks to illustrate the potential role MRgRT could play in personalizing rectal cancer treatment thus expanding the role of NOM in rectal cancer.
Sujet(s)
Imagerie interventionnelle par résonance magnétique , Traitement néoadjuvant/méthodes , Récidive tumorale locale/épidémiologie , Radiothérapie guidée par l'image/méthodes , Tumeurs du rectum/thérapie , Prise de décision clinique , Survie sans rechute , Humains , Récidive tumorale locale/prévention et contrôle , Stadification tumorale , Sélection de patients , Proctectomie , Tumeurs du rectum/diagnostic , Tumeurs du rectum/mortalité , Rectum/imagerie diagnostique , Rectum/anatomopathologie , Rectum/effets des radiations , Rectum/chirurgieRÉSUMÉ
Background: Multiparametric magnetic resonance imaging (mpMRI) has emerged as a non-invasive modality to diagnose and monitor prostate cancer. Quantitative metrics on the regions of abnormality have shown to be useful descriptors to discriminate clinically significant cancers. In this study, we evaluate the reproducibility of quantitative imaging features using repeated mpMRI on the same patients. Methods: We retrospectively obtained the deidentified records of patients, who underwent two mpMRI scans within 2 weeks of the first baseline scan. The patient records were obtained as deidentified data (including imaging), obtained through the TCIA (The Cancer Imaging Archive) repository and analyzed in our institution with an institutional review board-approved Health Insurance Portability and Accountability Act-compliant retrospective study protocol. Indicated biopsied regions were used as a marker for our study radiologists to delineate the regions of interest. We extracted 307 quantitative features in each mpMRI modality [T2-weighted MR sequence image (T2w) and apparent diffusion coefficient (ADC) with b values of 0 and 1,400 mm/s2] across the two sequential scans. Concordance correlation coefficients (CCCs) were computed on the features extracted from sequential scans. Redundant features were removed by computing the coefficient of determination (R 2) among them and replaced with a feature that had the highest dynamic range within intercorrelated groups. Results: We have assessed the reproducibility of quantitative imaging features among sequential scans and found that habitat region characterization improves repeatability in ADC maps. There were 19 T2w features and two ADC features in radiologist drawn regions (native raw image), compared to 18 T2w and 15 ADC features in habitat regions (sphere), which were reproducible (CCC ≥0.65) and non-redundant (R 2 ≥ 0.99). We also found that z-transformation of the images prior to feature extraction reduced the number of reproducible features with no detrimental effect. Conclusion: We have shown that there are quantitative imaging features that are reproducible across sequential prostate mpMRI acquisition at a preset level of filters. We also found that a habitat approach improves feature repeatability in ADC. A validated set of reproducible image features in mpMRI will allow us to develop clinically useful disease risk stratification, enabling the possibility of using imaging as a surrogate to invasive biopsies.
RÉSUMÉ
Testicular cancers are a group of uncommon malignancies that account for less than 1% of new cancer cases per year in the United States and globally. The disease typically affects men between the ages of 20-44, and the overwhelming majority of tumors are germ cell in origin. Most cases of testicular cancer are organ confined at diagnosis and have a good overall prognosis. Testicular cancers are staged by the tumor, node, metastasis, serum markers (TNMS) classification set forth by the American Joint Commission on Cancer staging. Diagnostic imaging plays a crucial role in initial staging, specifically in assessing the primary tumor prior to orchiectomy and evaluating for regional and/or distant metastasis. Multimodality imaging is used for initial staging, with ultrasound and computed tomography (CT) most commonly utilized. Diagnostic imaging is also important in evaluating response in patients who initially present with metastatic disease as well as in patients who are undergoing surveillance. Typically, CT is used for response assessment and surveillance, with magnetic resonance imaging (MRI) and positron emission tomography (PET) serving as adjunct modalities. This article reviews the role of various diagnostic imaging modalities and how they are employed in the diagnosis, staging, response assessment and surveillance of primary testicular cancer.
RÉSUMÉ
OBJECTIVE: To test the hypothesis that there is a measureable upward motion of the diaphragm during prolonged breath-holds that could have a detrimental effect on image quality in liver MRI and to identify factor that potentially influence the magnitude of this motion. METHODS: 15 healthy volunteers underwent MRI examination using prolonged breath-holds in the maximum inspiratory position and a moderate inspiratory position. Coronal T1 weighted three-dimensional gradient echo sequences of the entire thorax were acquired every 6 s during breath-holding allowing the calculation of total lung volume and the measurement of the absolute position of the dome of the liver. The potential impact of subject's gender, body mass index, and total lung capacity on the change in lung volume/diaphragmatic motion was assessed using random coefficient regression. RESULTS: All volunteers demonstrated a slow reduction of the total lung volume during prolonged breath-holding up to 123 ml. There was a measurable associated upward shift of the diaphragm, measuring up to 5.6 mm after 24 s. There was a positive correlation with female gender (p = 0.037) and total lung volume (p = 0.005) and a negative association with BMI (p = 0.012) for the maximum inspiratory position only. CONCLUSION: There is a measureable reduction of lung volumes with consecutive upward shift of the diaphragm during prolonged breath-holding which likely contributes to motion artifacts in liver MRI. ADVANCES IN KNOWLEDGE: There is a measureable gas exchange-related reduction of lung volumes with consecutive upward shift of the diaphragm during prolonged breath-holding which likely contributes to motion artifacts in liver MRI. Correcting for this predictable upward shift has potential to improve image quality.The magnitude of this effect does not seem to be related to gender, BMI or total lung capacity if a moderate inspiratory position is used.
Sujet(s)
Abdomen/physiologie , Pause respiratoire , Foie , Adulte , Artéfacts , Muscle diaphragme/physiologie , Femelle , Volontaires sains , Humains , Inspiration/physiologie , Mesure des volumes pulmonaires , Imagerie par résonance magnétique/méthodes , Mâle , Adulte d'âge moyen , Mouvement/physiologie , Échanges gazeux pulmonaires/physiologie , Jeune adulteRÉSUMÉ
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for patients with low-grade mucinous adenocarcinoma (LGMA) is most effective when complete cytoreduction is achieved. We externally validated two radiographic scoring systems to predict resectability and assessed radiographic response to systemic chemotherapy (SCT). METHODS: Patients with LGMA who received preoperative SCT followed by CRS/HIPEC from 2013 to 2016 were identified. CT scans were graded by six physicians using the simplified radiologic score (SRS) and simplified preoperative assessment of appendiceal tumor (SPAAT) systems. Positive and negative predictive values (PPV, NPV) were calculated by comparing to completeness of cytoreduction. Inter-rater agreement was assessed using the intraclass correlation coefficient (ICC). RESULTS: Twenty-four patients had preoperative SCT followed by CRS/HIPEC. Thirteen patients underwent incomplete CRS and 11 patients complete CRS. Scoring of the preoperative CT had a PPV of complete cytoreduction of 75% and 66.7% for SRS and SPAAT, respectively. NPV was 83.4% and 88.9% for SRS and SPAAT, respectively. ICC for the preoperative SRS and SPAAT score was 0.826 (95% confidence interval [CI]: 0.720-0.910] and 0.788 [0.667-0.888). Comparison of CT scans before and after SCT recorded an increase in calculated scores in 45.8% (SRS) and 50% (SPAAT) of patients. CONCLUSIONS: External validation of two radiographic scoring systems to predict complete cytoreduction showed that inter-rater agreement for both systems was good. Both scoring systems predicted incomplete cytoreduction. Applying a systematic approach to preoperative imaging review is recommended to improve treatment selection by minimizing morbidity associated with incomplete CRS and help to set patient expectations.
Sujet(s)
Adénocarcinome mucineux/imagerie diagnostique , Tumeurs de l'appendice/imagerie diagnostique , Interventions chirurgicales de cytoréduction , Hyperthermie provoquée , Soins préopératoires/normes , Adénocarcinome mucineux/thérapie , Adulte , Sujet âgé , Antinéoplasiques/usage thérapeutique , Tumeurs de l'appendice/thérapie , Études de cohortes , Association thérapeutique , Femelle , Humains , Mâle , Adulte d'âge moyen , Grading des tumeurs , Valeur prédictive des tests , Pronostic , Études rétrospectives , Tomodensitométrie/normesRÉSUMÉ
BACKGROUND: Identification of imaging traits to discriminate clinically significant prostate cancer is challenging due to the multi focal nature of the disease. The difficulty in obtaining a consensus by the Prostate Imaging and Data Systems (PI-RADS) scores coupled with disagreements in interpreting multi-parametric Magnetic Resonance Imaging (mpMRI) has resulted in increased variability in reporting findings and evaluating the utility of this imaging modality in detecting clinically significant prostate cancer. This study assess the ability of radiological traits (semantics) observed on multi-parametric Magnetic Resonance images (mpMRI) to discriminate clinically significant prostate cancer. METHODS: We obtained multi-parametric MRI studies from 103 prostate cancer patients with 167 targeted biopsies from a single institution. The study was approved by our Institutional Review Board (IRB) for retrospective analysis. The biopsy location had been identified and marked by a clinical radiologist for targeted biopsy based on initial study interpretation. Using the target locations, two study radiologists independently re-evaluated the scans and scored 16 semantic traits on a point scale (up to 5 levels) based on mpMRI images. The semantic traits describe size, shape, and border characteristics of the prostate lesion, as well as presence of disease around lymph nodes (lymphadenopathy). We built a linear classifier model on these semantic traits and related to pathological outcome to identify clinically significant tumors (Gleason Score ≥ 7). The discriminatory ability of the predictors was tested using cross validation method randomly repeated and ensemble values were reported. We then compared the performance of semantic predictors with the PI-RADS predictors. RESULTS: We found several semantic features individually discriminated high grade Gleason score (ADC-intensity, Homogeneity, early-enhancement, T2-intensity and extraprostatic extention), these univariate predictors had an average area under the receiver operator characteristics (AUROC) ranging from 0.54 to 0.68. Multivariable semantic predictors with three features (ADC-intensity; T2-intensity, enhancement homogenicity) had an average AUROC of 0.7 [0.43, 0.94]. The PI-RADS based predictor had average AUROC of 0.6 [0.47, 0.75]. CONCLUSION: We find semantics traits are related to pathological findings with relatively higher reproducibility between radiologists. Multivariable predictors formed on these traits shows higher discriminatory ability compared to PI-RADS scores.
Sujet(s)
Imagerie par résonance magnétique/méthodes , Tumeurs de la prostate/imagerie diagnostique , Sémantique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Humains , Mâle , Adulte d'âge moyen , Grading des tumeurs , Tumeurs de la prostate/anatomopathologie , Études rétrospectivesRÉSUMÉ
We present the conventional cardiac magnetic resonance (CMR) protocol for evaluating a suspected thrombus and highlight emerging techniques. The appearance of a mass on certain magnetic resonance (MR) sequences can help differentiate a thrombus from competing diagnoses such as a tumor. T1 and T2 signal characteristics of a thrombus are related to the evolution of hemoglobin properties. A thrombus typically does not enhance following contrast administration, which also helps differentiation from a tumor. We also highlight the emerging role of T1 mapping in the evaluation of a thrombus, which can add another level of support in diagnosis. Prior to any CMR exam, patient screening and interviews are critical to ensure safety and to optimize patient comfort. Effective communication during the exam between the technologist and the patient promotes proper breath holding technique and higher quality images. Volumetric post processing and structured reporting are helpful to ensure that the radiologist answers the ordering services' question and communicates these results effectively. Optimal pre-MR safety evaluation, CMR exam execution, and post exam processing and reporting allow for delivery of high quality radiological service in the evaluation of a suspected cardiac thrombus.
Sujet(s)
Cardiopathies/imagerie diagnostique , Coeur/imagerie diagnostique , Imagerie par résonance magnétique/méthodes , Thrombose/imagerie diagnostique , Femelle , Humains , Mâle , Adulte d'âge moyenRÉSUMÉ
PURPOSE: Magnetic resonance imaging (MRI)-based intracavitary brachytherapy offers several advantages over computed tomography (CT)-based brachytherapy, but many centers are unable to offer it at the time of brachytherapy because of logistic and/or financial considerations. We have implemented a method of integrating MRI into a CT-guided, high-dose-rate intracavitary brachytherapy workflow in clinics that do not have immediately available MRI capability. METHODS: At our institution, patients receiving high-dose-rate intracavitary brachytherapy as a component of the definitive treatment of cervical cancer have a Smit sleeve placed during the first brachytherapy fraction in a dedicated suite with in-room CT-on-rails. After the first fraction of brachytherapy, an MRI is obtained with the Smit sleeve, but no applicator, in place. For each subsequent fraction, CT scans are coregistered to the MRI scan by the Smit sleeve. The gross target volume is defined by MRI and overlaid on the CT images for each brachytherapy treatment for dose optimization. RESULTS: This MRI-integrated workflow adds <5 minutes to the brachytherapy session for image fusion. Our initial clinical experience suggests that this approach is feasible and results in target volume reductions compared with CT-alone brachytherapy. CONCLUSIONS: Our proposed combination MRI and/or CT workflow is a feasible compromise to preserve an efficient workflow while integrating MRI target delineation, and it provides many of the advantages of both MRI- and CT-based brachytherapy. The future collection and analysis of clinical data will serve to compare the proposed approach to non-MRI containing techniques.
Sujet(s)
Curiethérapie/méthodes , Traitement d'image par ordinateur , Imagerie par résonance magnétique , Tomodensitométrie , Tumeurs du col de l'utérus/radiothérapie , Flux de travaux , Femelle , Humains , Radiothérapie guidée par l'image/méthodes , Études rétrospectivesRÉSUMÉ
PURPOSE: To compare the inter- and intraobserver variability with manual region of interest (ROI) placement versus that with software-assisted semiautomatic lesion segmentation and histogram analysis with respect to quantitative dynamic contrast material-enhanced (DCE) MR imaging determinations of the volume transfer constant (K(trans)). MATERIALS AND METHODS: The study was approved by the institutional review board and compliant with HIPAA. The requirement to obtain informed consent was waived. Fifteen DCE MR imaging studies of the female pelvis defined the study group. Uterine fibroids were used as a perfusion model. Three varying types of lesion measurements were performed by five readers on each study by using DCE MR imaging perfusion analysis software with manual ROI placement and a semiautomatic lesion segmentation and histogram analysis solution. Intra- and interreader variability of measurements of K(trans) with the different measurement types was calculated. RESULTS: The overall interobserver variability of K(trans) with manual ROI placement (mean, 28.5% ± 9.3) was reduced by 42.5% when the semiautomatic, software-assisted lesion measurement method was used (16.4% ± 6.2). Whole-lesion measurement showed the lowest interobserver variability with both measurement methods (20.1% ± 4.3 with the manual method vs 10.8% ± 2.6 with the semiautomatic method). The overall intrareader variability with the manual ROI method (7.6% ± 10.6) was not significantly different from that with the semiautomatic method (7.3% ± 10.8), but the intraclass correlation coefficient for intrareader reproducibility improved from 0.86 overall with the manual method to 0.99 with the semiautomatic method. CONCLUSION: A semiautomatic lesion segmentation and histogram analysis approach can provide a significant reduction in interobserver variability for DCE MR imaging measurements of K(trans) when compared with manual ROI methods, whereas intraobserver reproducibility is improved to some extent.
Sujet(s)
Produits de contraste/pharmacocinétique , Léiomyome/métabolisme , Léiomyome/anatomopathologie , Angiographie par résonance magnétique/méthodes , Reconnaissance automatique des formes/méthodes , Tumeurs de l'utérus/métabolisme , Tumeurs de l'utérus/anatomopathologie , Adulte , Intelligence artificielle , Simulation numérique , Femelle , Humains , Interprétation d'images assistée par ordinateur/méthodes , Adulte d'âge moyen , Modèles biologiques , Pelvis/anatomopathologie , Reproductibilité des résultats , Sensibilité et spécificitéRÉSUMÉ
PURPOSE: To test the reproducibility of model-derived quantitative and semiquantitative pharmacokinetic parameters among various commercially available perfusion analysis solutions for dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging. MATERIALS AND METHODS: The study was institutional review board approved and HIPAA compliant, with waiver of informed consent granted. The study group consisted of 15 patients (mean age, 44 years; range, 28-60 years), with 15 consecutive 1.5-T DCE MR imaging studies performed between October 1, 2010, and December 27, 2010, prior to uterine fibroid embolization. Studies were conducted by using variable-flip-angle T1 mapping and four-dimensional, time-resolved MR angiography with interleaved stochastic trajectories. Images from all DCE MR imaging studies were postprocessed with four commercially available perfusion analysis solutions by using a Tofts and Kermode model paradigm. Five observers measured pharmacokinetic parameters (volume transfer constant [K(trans)], v(e) [extracellular extravascular volume fraction], k(ep)[K(trans)/v(e)], and initial area under the gadolinium curve [iAUGC]) three times for each imaging study with each perfusion analysis solution (between March 13, 2011, and September 8, 2011) by using two different region-of-interest methods, resulting in 1800 data points. RESULTS: After normalization of data output, significant differences in mean values were found for the majority of perfusion analysis solution combinations. The within-subject coefficient of variation among perfusion analysis solutions was 48.3%-68.8% for K(trans), 37.2%-60.3% for k(ep), 27.7%-74.1% for v(e), and 25.1%-61.2% for iAUGC. The intraclass correlation coefficient revealed only poor to moderate consistency among pairwise perfusion analysis solution comparisons (K(trans), 0.33-0.65; k(ep), 0.02-0.81; v(e), -0.03 to 0.72; and iAUGC, 0.47-0.78). CONCLUSION: A considerable variability for DCE MR imaging pharmacokinetic parameters (K(trans), k(ep), v(e), iAUGC) was found among commercially available perfusion analysis solutions. Therefore, clinical comparability across perfusion analysis solutions is currently not warranted. Agreement on a postprocessing standard is paramount prior to establishing DCE MR imaging as a widely incorporated biomarker.
Sujet(s)
Produits de contraste/pharmacocinétique , Léiomyome/métabolisme , Léiomyome/anatomopathologie , Angiographie par résonance magnétique/méthodes , Modèles biologiques , Tumeurs de l'utérus/métabolisme , Tumeurs de l'utérus/anatomopathologie , Adulte , Simulation numérique , Femelle , Humains , Interprétation d'images assistée par ordinateur/méthodes , Adulte d'âge moyen , Pelvis/anatomopathologie , Reproductibilité des résultats , Sensibilité et spécificitéRÉSUMÉ
PURPOSE: To determine the reproducibility of TWIST-derived (Time-Resolved Angiography with Interleaved Stochastic Trajectories) quantitative dynamic contrast enhanced (DCE) MRI in a uterine fibroid model. MATERIALS AND METHODS: The institutional review board approved this retrospective study. Dynamic contrast-enhanced TWIST datasets from 15 randomly selected 1.5 Tesla pelvic MR studies were postprocessed. Five readers recorded kinetic parameters (K(trans) [volume transfer constant], ve [extracellular extravascular space volume], kep [flux rate constant], iAUC [initial area under the gadolinium-time curve]) of the largest uterine fibroid using three region-of-interest (ROI) selection methods. Measurements were randomized and repeated three times, and measures of reproducibility were calculated. RESULTS: The intra-rater coefficients of variation (CVs, brackets indicate 95% confidence intervals) varied from 4.6% to 7.6% (K(trans) 7.6% [6.1%, 9.1%], kep 7.2% [5.9%, 8.5%], ve 4.6% [3.8%, 5.4%], and iAUC 7.2% [6.1%, 8.3%]). ve was the most reproducible (P < 0.05). Inter-rater reproducibility was significantly (P < 0.05) greater for the large ROI method (range of intraclass correlation coefficients [ICCs] = 0.80-0.98 versus 0.48-0.63 [user-defined ROI] versus 0.41-0.69 [targeted ROI]). The uterine fibroid accounted for the greatest fraction of variance for the large ROI method (range across kinetic parameters: 83-98% versus 56-69% [user-defined ROI] versus 47-74% [targeted ROI]). The reader accounted for the greatest fraction of variance for the user-defined ROI method (0.4-14.1% versus 0.1-3.0% [large ROI] versus <0.1-1.5% [targeted ROI]). CONCLUSION: Changes in TWIST-derived DCE-MRI kinetic parameters of up to 9-15% may be attributable to measurement error. Large DCE-MRI regions of interest are the most reproducible across multiple readers.
Sujet(s)
Interprétation d'images assistée par ordinateur/méthodes , Léiomyome/anatomopathologie , Angiographie par résonance magnétique/méthodes , Méglumine/analogues et dérivés , Néovascularisation pathologique/anatomopathologie , Composés organométalliques , Tumeurs de l'utérus/anatomopathologie , Adulte , Produits de contraste , Femelle , Humains , Amélioration d'image/méthodes , Léiomyome/complications , Adulte d'âge moyen , Néovascularisation pathologique/étiologie , Biais de l'observateur , Reproductibilité des résultats , Sensibilité et spécificité , Tumeurs de l'utérus/complicationsRÉSUMÉ
This study tests whether the utilization of an electronic breath-hold monitoring device improves breath-hold reproducibility during computed tomographic (CT) scanning. Two cohorts of 40 patients underwent dual-phase abdominal CT scans, either with a breath-hold monitoring device or with the standard breath-holding technique. Two blinded readers measured the differences in diaphragmatic position between phases. There was no statistical difference in diaphragmatic position (P=.14) between the monitored (8.5±11.5 mm) and control (5.6±5.2 mm) cohorts. Ten percent of patients from the monitored cohort had greater than 20 mm of deviation, versus 0%-2.5% for the control cohort. Reproduction of breath-holding position remains challenging, even with a monitoring system.
Sujet(s)
Artéfacts , Rétroaction biologique (psychologie)/instrumentation , Pause respiratoire , Amélioration d'image/méthodes , Positionnement du patient/instrumentation , Tomodensitométrie/instrumentation , Rétroaction biologique (psychologie)/méthodes , Conception d'appareillage , Analyse de panne d'appareillage , Humains , Positionnement du patient/méthodes , Reproductibilité des résultats , Sensibilité et spécificité , Méthode en simple aveugle , Tomodensitométrie/méthodesRÉSUMÉ
PURPOSE: The aim of this study was to assess the accuracy of iodine quantification based on spectral dual-energy computed tomography (DECT) extraction with additional noise reduction using iterative reconstruction in simulated optimal and obese patient environments. MATERIALS AND METHODS: Two custom-designed DECT phantoms were containing 10 vials with iodine concentrations representing arterial/parenchymal enhancement ranging from water isodensity to -150 Hounsfield units and, in addition, 40 vials simulating enhancement seen in nondiluted thoracic inlet vasculature and urinary bladder/renal collecting systems of up to -2000 Hounsfield units.Dual-energy computed tomography acquisition was performed using a dual-source scanner at 140 kVp/90 mAs and 80 kVp/495 mAs. Backprojection-based soft tissue kernels and corresponding iteratively reconstructed kernels generated dual-energy series used for iodine extraction.Fractional variations between known and spectrally determined iodine concentration were calculated for each concentration step; paired t tests evaluated variations between backprojected and iteratively reconstructed data sets for small and obese phantoms. Bland-Altman plots with regression analyses assessed concentration differences observed in backprojected and iteratively reconstructed data. RESULTS: For backprojected data, mean concentration variations of 8.7% ± 8.4 and 12.2% ± 6.3 were detected in small and large phantoms, respectively, compared with significantly less variation observed in iteratively reconstructed data with 6.1% ± 6.2 and 11.0% ± 6.5, respectively. Dual-energy quantification systematically overestimated concentrations in lower concentration ranges and underestimated concentrations in higher concentration ranges. Regression analyses showed cubic distribution of concentration differences for backprojected (R = 0.697) and linear distribution for iteratively reconstructed data (R = 0.701). CONCLUSION: Spectral DECT-based iodine quantification is able to accurately quantify iodine in phantoms simulating optimal and large patients; iterative reconstruction improves the accuracy of iodine detection. Systematic deviations of the spectrally determined iodine concentrations could potentially be corrected with weighting curves.
Sujet(s)
Produits de contraste , Iode , Tomodensitométrie multidétecteurs/méthodes , Fantômes en imagerie , Abdomen/anatomopathologie , Algorithmes , Humains , Obésité/anatomopathologie , Analyse de régression , LogicielRÉSUMÉ
OBJECTIVES: To investigate the ability of staging computed tomography (CT) without bowel preparation to accurately localize colonic tumors compared to optical colonoscopy. METHODS: The local institutional review board approved this retrospective and HIPAA-compliant study. Forty-six patients with colonic adenocarcinoma, preoperative colonoscopy, and staging CT within 60 days of resection were included. Patients underwent contrast enhanced CT imaging without bowel preparation or oral contrast. The colon was divided into four segments with the operative reports used as the standard. Rectal and cecal cancers were excluded. CT scans were reviewed by 5 readers in a segmental binary fashion using a 5-point confidence scale in two sessions blinded and unblinded to the colonoscopy report. RESULTS: At surgery 49 tumors were found in 46 patients. Readers detected 86.1%, 74.3%, and 66.9% of lesions with 92.0%, 94.1%, and 95.4% accuracy for confidence scores of ≥ 3, ≥ 4, and 5. CT interobserver agreement was good (κ=0.82) for the unblinded and moderate (κ=0.60) for the blinded read. Colonoscopic localization was only 78.7% accurate with 2 tumors undiscovered. Colonoscopic accuracy was low in the descending colon (57.1%) and the transverse colon (55.6%). CONCLUSIONS: Preoperative staging CT is more accurate than colonoscopy in the localization of colonic tumors.
Sujet(s)
Côlon/imagerie diagnostique , Tumeurs du côlon/imagerie diagnostique , Coloscopie virtuelle par tomodensitométrie/méthodes , Coloscopie/méthodes , Amélioration d'image radiographique/méthodes , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Produits de contraste , Femelle , Humains , Mâle , Adulte d'âge moyen , Biais de l'observateur , Imagerie optique/méthodes , Reproductibilité des résultats , Sensibilité et spécificitéRÉSUMÉ
PURPOSE: The purpose of this study was to prospectively determine the diagnostic accuracy of diffusion-weighted imaging (DWI) using MRI in the staging of thoracic lymph nodes in patients with lung cancer, and to compare the performance to that of PET/CT. PATIENTS AND METHOD: 20 consecutive patients (pts) with histologically proven lung cancer were included in this study. In all pts FDG-PET/CT was routinely performed to stage lung carcinoma. Additionally, MRI (1.5T) was performed including native T1w, T1w post contrast medium, T2w, and DWI sequences. Regarding the N stage based on the results of the PET/CT there were 5 patients with N0, 3 patients with N1, 5 patients with N2 and 7 patients with N3. Image analysis was performed by two radiologists (R1 and R2), respectively. The reviewers had to chose between 1 (at least one lymph node within a station is malignant) or 0 (no lymph nodes suspicious for malignancy). First the T1 post contrast sequence was analyzed. In a second step the DWI sequence (b=800) was analyzed. Both steps were performed in a blinded fashion. RESULTS: MR imaging with or without DWI only agreed with the results of the PET/CT regarding the N stage in 80% of the patients-15% were understaged and 5% overstaged. There was excellent interobserver agreement; the N-staging result only differed in 1 patient for DWI, resulting in correlation coefficients of 0.98 for DWI and 1.0 for MRI. Compared to PET-CT MRI overstaged one and understaged 4 patients, while DWI overstaged one and understaged 3 patients. This resulted in correlation coefficients of 0.814 (R1 and R2) for MRI and 0.815 (R1) and 0.804 (R2) for DWI. Regarding the ADC values there were no significant differences between ipsilateral hilar (1.03 mm(2)/s ± 0.13), subcarinal (0.96 mm(2)/s±0.24), ipsilateral mediastinal (1.0mm(2)/s ± 0.18), contralateral mediastinal (0.93 mm(2)/s ± 0.23) and supraclavicular (0.9 mm(2)/s ± 0.23) lymph nodes. CONCLUSION: Diffusion-weighted imaging does not show a clear advantage over conventional MR protocols in the N-staging of lung cancer. MRI with or without DWI shows a moderately correlation with PET/CT with a tendency for understaging.
Sujet(s)
Imagerie par résonance magnétique de diffusion/méthodes , Fluorodésoxyglucose F18 , Tumeurs du poumon/diagnostic , Tomographie par émission de positons/méthodes , Technique de soustraction , Tomodensitométrie/méthodes , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Stadification tumorale , Radiopharmaceutiques , Reproductibilité des résultats , Sensibilité et spécificité , Intégration de systèmesRÉSUMÉ
PURPOSE: To investigate the enhancement characteristics of liver parenchyma and portal vein as well as the portal vein-to liver contrast in Gd-EOB-DTPA- and Gd-BOPTA-enhanced abdominal MRI. MATERIALS AND METHODS: The local institutional review board approved this retrospective study. A total of 70 patients (30 female, 40 male) without relevant liver disease underwent either Gd-EOB-DTPA-enhanced (35 patients, dose 0.025 mmol/kg) or Gd-BOPTA-enhanced (35 patients, dose 0.1 mmol/kg) abdominal MRI. Signal-to-noise ratios (SNR) for the portal vein and the liver as well as portal vein-to-liver contrast-to-noise ratios (CNR) were calculated for three consecutive arterial phases, one portal venous phase and one delayed imaging phase. RESULTS: The liver SNR showed higher values for the Gd-BOPTA group in the arterial and portal venous phases (statistically significant for the second and third arterial phase), while the liver SNR in the delayed phase was higher for the Gd-EOB-DTPA group. The portal venous SNR as well as the portal vein-to-liver CNR was higher in the Gd-BOPTA group in all imaging phases (statistically significant in all phases except for the first arterial phase). CONCLUSION: The enhancement of liver parenchyma and portal vein as well as the portal vein-to-liver contrast in the arterial and portal venous imaging phases were higher for patients receiving Gd-BOPTA compared with Gd-EOB-DTPA at the respective recommended doses. Gd-BOPTA might therefore enable better evaluation of the portal vein.